US 7541034
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
granted A61KA61K38/00A61K47/6849
Quick answer
US patent 7541034 (Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K38/00, A61K47/6849, A61P, A61P35/00